About APLS Dividend Returns
Apellis Pharmaceuticals, Inc. (APLS) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of APLS over the past year?
Apellis Pharmaceuticals, Inc. (APLS) delivered a return of -16.66% over the past year. Since APLS does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in APLS be worth today?
A $10,000 investment in Apellis Pharmaceuticals, Inc. one year ago would be worth $8,334 today, representing a loss of $1,666.
Q3Does APLS pay dividends?
Apellis Pharmaceuticals, Inc. (APLS) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For APLS, the total return equals the price-only return.
Q4Did APLS beat the S&P 500?
No, Apellis Pharmaceuticals, Inc. (APLS) underperformed the S&P 500 by 32.11 percentage points over the past year. APLS delivered a total return of -16.66%, compared to the S&P 500's 15.45%. This means a passive S&P 500 index fund outperformed APLS by 32.11pp during this period.
Q5What is APLS's worst drawdown?
Apellis Pharmaceuticals, Inc. (APLS) experienced a maximum drawdown of -37.08% over the past year, declining from its peak on 2025-03-05 to its trough on 2025-05-15. The stock recovered to its prior peak by 2025-08-13. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is APLS's long-term total return over 10, 20, or 30 years?
Apellis Pharmaceuticals, Inc. (APLS) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is 49.4% (4.1% CAGR) — $10,000 would have grown to $14,939. Over 20 years: 49.4% total return (2.0% CAGR) — $10,000 → $14,940. Over 30 years: 49.4% total return (1.3% CAGR) — $10,000 → $14,940. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was APLS's best and worst year?
Apellis Pharmaceuticals, Inc.'s best calendar year was 2019 with a total return of 124.8%. Its worst year was 2024 with a total return of -47.9%. This range shows the volatility investors should expect — the difference between the best and worst year is 172.7 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).